These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9853996)

  • 1. Oral intake of perphenazine decanoate.
    Larsen NE
    Ther Drug Monit; 1998 Dec; 20(6):724. PubMed ID: 9853996
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of linearity of kinetics for the neuroleptics perphenazine and zuclopenthixol.
    Linnet K
    Eur J Clin Pharmacol; 1997; 52(4):317-8. PubMed ID: 9248772
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic behaviour of perphenazine in sheep after intramuscular administration of a long-acting formulation.
    Pedernera-Romano C; Ruiz-de-la-Torre JL; Castells G; Manteca X; Cristòfol C
    J Vet Pharmacol Ther; 2009 Jun; 32(3):306-8. PubMed ID: 19646098
    [No Abstract]   [Full Text] [Related]  

  • 4. A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.
    Talvik M; Nordström AL; Larsen NE; Jucaite A; Cervenka S; Halldin C; Farde L
    Psychopharmacology (Berl); 2004 Sep; 175(2):148-53. PubMed ID: 15007534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the optimal perphenazine decanoate dose based on blood samples drawn within the first three weeks.
    Larsen NE; Hansen LB
    Ther Drug Monit; 1989 Nov; 11(6):642-6. PubMed ID: 2595744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perphenazine decanoate and cis(z)-flupentixol decanoate in maintenance treatment of schizophrenic outpatients. Serum levels at the minimum effective dose.
    Kistrup K; Gerlach J; Aaes-Jørgensen T; Larsen NE
    Psychopharmacology (Berl); 1991; 105(1):42-8. PubMed ID: 1745710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a gas chromatographic-mass spectrometric method for quantitative determination of perphenazine in rabbit plasma after sublingual administration.
    Turunen E; Lehtonen M; Järvinen T; Jarho P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):51-7. PubMed ID: 18667368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot perphenazine decanoate and enanthate for schizophrenia.
    Quraishi S; David A
    Cochrane Database Syst Rev; 2000; (2):CD001717. PubMed ID: 10796445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
    Knudsen P; Hansen LB; Højholdt K; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():41-50. PubMed ID: 3934921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of perphenazine and its metabolites in plasma by high-performance liquid chromatography and coulometric detection.
    Foglia JP; Sorisio D; Kirshner MA; Mulsant BH; Perel JM
    J Chromatogr B Biomed Appl; 1995 Jun; 668(2):291-7. PubMed ID: 7581864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of Haloperidol, Fluphenazine, Perphenazine, and Thiothixene in Serum or Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Slawson MH; Johnson-Davis KL
    Methods Mol Biol; 2016; 1383():49-57. PubMed ID: 26660173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of perphenazine and its sulphoxide metabolite in human plasma after therapeutic doses by gas chromatography.
    Larsen NE; Naestoft J
    J Chromatogr; 1975 Jun; 109(2):259-64. PubMed ID: 1150819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high-performance liquid chromatographic method for the assay of perphenazine and its dealkylated metabolite in serum after therapeutic doses.
    Larsson M; Forsman A
    Ther Drug Monit; 1983 Jun; 5(2):225-8. PubMed ID: 6879648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humans.
    Appel L; Geffen Y; Heurling K; Eriksson C; Antoni G; Kapur S
    Eur Neuropsychopharmacol; 2009 Dec; 19(12):841-50. PubMed ID: 19717284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abscesses following prolonged intramuscular administration of perphenazine enantate.
    Starmark JE; Forsman A; Wahlström
    Acta Psychiatr Scand; 1980 Aug; 62(2):154-7. PubMed ID: 6110312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment.
    Knudsen P; Hansen LB; Larsen NE
    Acta Psychiatr Scand Suppl; 1985; 322():7-10. PubMed ID: 3865501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.
    Hansen CE; Larsen NE
    Psychopharmacologia; 1974 Jun; 37(1):31-6. PubMed ID: 4415024
    [No Abstract]   [Full Text] [Related]  

  • 19. An open-label tolerability study of BL-1020 antipsychotic: a novel gamma aminobutyric acid ester of perphenazine.
    Anand R; Geffen Y; Vasile D; Dan I
    Clin Neuropharmacol; 2010; 33(6):297-302. PubMed ID: 20921890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous UPLC-MS/MS assay for the detection of the traditional antipsychotics haloperidol, fluphenazine, perphenazine, and thiothixene in serum and plasma.
    Juenke JM; Brown PI; Urry FM; Johnson-Davis KL; McMillin GA
    Clin Chim Acta; 2013 Aug; 423():32-4. PubMed ID: 23618971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.